Selected research
Market Outlook & Growth Opportunities
Global External Anthelmintic for Dogs Market Outlook and Growth Opportunities 2026
Market perspective
The global External Anthelmintic for Dogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the External Anthelmintic for Dogs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the External Anthelmintic for Dogs market include FRONTLINE, Zoetis, Bayer, Virbac, Vetoquinol, NexGard, Merck Animal Health, Elanco and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global External Anthelmintic for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of External Anthelmintic for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents External Anthelmintic for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the External Anthelmintic for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.
External Anthelmintic for Dogs Segment by Company
FRONTLINE
Zoetis
Bayer
Virbac
Vetoquinol
NexGard
Merck Animal Health
Elanco
Boehringer Ingelheim
External Anthelmintic for Dogs Segment by Type
Spray
Drops
External Anthelmintic for Dogs Segment by Application
Research Institutions
Veterinary Clinics
Animal Shelters
Pet Owners
Others
External Anthelmintic for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global External Anthelmintic for Dogs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions External Anthelmintic for Dogs market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify External Anthelmintic for Dogs significant trends, drivers, influence factors in global and regions.
6. To analyze External Anthelmintic for Dogs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anthelmintic for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of External Anthelmintic for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anthelmintic for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the External Anthelmintic for Dogs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global External Anthelmintic for Dogs industry.
Chapter 3: Detailed analysis of External Anthelmintic for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of External Anthelmintic for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of External Anthelmintic for Dogs in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Spray
- Drops
Applications
- Research Institutions
- Veterinary Clinics
- Animal Shelters
- Pet Owners
- Others
Companies covered
- FRONTLINE
- Zoetis
- Bayer
- Virbac
- Vetoquinol
- NexGard
- Merck Animal Health
- Elanco
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global External Anthelmintic for Dogs Sales Value (2021-2032)
- 1.2.2 Global External Anthelmintic for Dogs Sales Volume (2021-2032)
- 1.2.3 Global External Anthelmintic for Dogs Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 External Anthelmintic for Dogs Market Dynamics
- 2.1 External Anthelmintic for Dogs Industry Trends
- 2.2 External Anthelmintic for Dogs Industry Drivers
- 2.3 External Anthelmintic for Dogs Industry Opportunities and Challenges
- 2.4 External Anthelmintic for Dogs Industry Restraints
3 External Anthelmintic for Dogs Market by Company
- 3.1 Global External Anthelmintic for Dogs Company Revenue Ranking in 2025
- 3.2 Global External Anthelmintic for Dogs Revenue by Company (2021-2026)
- 3.3 Global External Anthelmintic for Dogs Sales Volume by Company (2021-2026)
- 3.4 Global External Anthelmintic for Dogs Average Price by Company (2021-2026)
- 3.5 Global External Anthelmintic for Dogs Company Ranking (2024-2026)
- 3.6 Global External Anthelmintic for Dogs Company Manufacturing Base and Headquarters
- 3.7 Global External Anthelmintic for Dogs Company Product Type and Application
- 3.8 Global External Anthelmintic for Dogs Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global External Anthelmintic for Dogs Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 External Anthelmintic for Dogs Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 External Anthelmintic for Dogs Market by Type
- 4.1 External Anthelmintic for Dogs Type Introduction
- 4.1.1 Spray
- 4.1.2 Drops
- 4.2 Global External Anthelmintic for Dogs Sales Volume by Type
- 4.2.1 Global External Anthelmintic for Dogs Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global External Anthelmintic for Dogs Sales Volume by Type (2021-2032)
- 4.2.3 Global External Anthelmintic for Dogs Sales Volume Share by Type (2021-2032)
- 4.3 Global External Anthelmintic for Dogs Sales Value by Type
- 4.3.1 Global External Anthelmintic for Dogs Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global External Anthelmintic for Dogs Sales Value by Type (2021-2032)
- 4.3.3 Global External Anthelmintic for Dogs Sales Value Share by Type (2021-2032)
5 External Anthelmintic for Dogs Market by Application
- 5.1 External Anthelmintic for Dogs Application Introduction
- 5.1.1 Research Institutions
- 5.1.2 Veterinary Clinics
- 5.1.3 Animal Shelters
- 5.1.4 Pet Owners
- 5.1.5 Others
- 5.2 Global External Anthelmintic for Dogs Sales Volume by Application
- 5.2.1 Global External Anthelmintic for Dogs Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global External Anthelmintic for Dogs Sales Volume by Application (2021-2032)
- 5.2.3 Global External Anthelmintic for Dogs Sales Volume Share by Application (2021-2032)
- 5.3 Global External Anthelmintic for Dogs Sales Value by Application
- 5.3.1 Global External Anthelmintic for Dogs Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global External Anthelmintic for Dogs Sales Value by Application (2021-2032)
- 5.3.3 Global External Anthelmintic for Dogs Sales Value Share by Application (2021-2032)
6 External Anthelmintic for Dogs Regional Sales and Value Analysis
- 6.1 Global External Anthelmintic for Dogs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global External Anthelmintic for Dogs Sales by Region (2021-2032)
- 6.2.1 Global External Anthelmintic for Dogs Sales by Region: 2021-2026
- 6.2.2 Global External Anthelmintic for Dogs Sales by Region (2027-2032)
- 6.3 Global External Anthelmintic for Dogs Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global External Anthelmintic for Dogs Sales Value by Region (2021-2032)
- 6.4.1 Global External Anthelmintic for Dogs Sales Value by Region: 2021-2026
- 6.4.2 Global External Anthelmintic for Dogs Sales Value by Region (2027-2032)
- 6.5 Global External Anthelmintic for Dogs Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America External Anthelmintic for Dogs Sales Value (2021-2032)
- 6.6.2 North America External Anthelmintic for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe External Anthelmintic for Dogs Sales Value (2021-2032)
- 6.7.2 Europe External Anthelmintic for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific External Anthelmintic for Dogs Sales Value (2021-2032)
- 6.8.2 Asia-Pacific External Anthelmintic for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America External Anthelmintic for Dogs Sales Value (2021-2032)
- 6.9.2 South America External Anthelmintic for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa External Anthelmintic for Dogs Sales Value (2021-2032)
- 6.10.2 Middle East & Africa External Anthelmintic for Dogs Sales Value Share by Country, 2025 VS 2032
7 External Anthelmintic for Dogs Country-level Sales and Value Analysis
- 7.1 Global External Anthelmintic for Dogs Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global External Anthelmintic for Dogs Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global External Anthelmintic for Dogs Sales by Country (2021-2032)
- 7.3.1 Global External Anthelmintic for Dogs Sales by Country (2021-2026)
- 7.3.2 Global External Anthelmintic for Dogs Sales by Country (2027-2032)
- 7.4 Global External Anthelmintic for Dogs Sales Value by Country (2021-2032)
- 7.4.1 Global External Anthelmintic for Dogs Sales Value by Country (2021-2026)
- 7.4.2 Global External Anthelmintic for Dogs Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.5.2 USA External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.9.2 France External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.16.2 China External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.19.2 India External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt External Anthelmintic for Dogs Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt External Anthelmintic for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt External Anthelmintic for Dogs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 FRONTLINE
- 8.1.1 FRONTLINE Company Information
- 8.1.2 FRONTLINE Business Overview
- 8.1.3 FRONTLINE External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.1.4 FRONTLINE External Anthelmintic for Dogs Product Portfolio
- 8.1.5 FRONTLINE Recent Developments
- 8.2 Zoetis
- 8.2.1 Zoetis Company Information
- 8.2.2 Zoetis Business Overview
- 8.2.3 Zoetis External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Zoetis External Anthelmintic for Dogs Product Portfolio
- 8.2.5 Zoetis Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Bayer External Anthelmintic for Dogs Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Virbac
- 8.4.1 Virbac Company Information
- 8.4.2 Virbac Business Overview
- 8.4.3 Virbac External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Virbac External Anthelmintic for Dogs Product Portfolio
- 8.4.5 Virbac Recent Developments
- 8.5 Vetoquinol
- 8.5.1 Vetoquinol Company Information
- 8.5.2 Vetoquinol Business Overview
- 8.5.3 Vetoquinol External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Vetoquinol External Anthelmintic for Dogs Product Portfolio
- 8.5.5 Vetoquinol Recent Developments
- 8.6 NexGard
- 8.6.1 NexGard Company Information
- 8.6.2 NexGard Business Overview
- 8.6.3 NexGard External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.6.4 NexGard External Anthelmintic for Dogs Product Portfolio
- 8.6.5 NexGard Recent Developments
- 8.7 Merck Animal Health
- 8.7.1 Merck Animal Health Company Information
- 8.7.2 Merck Animal Health Business Overview
- 8.7.3 Merck Animal Health External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Merck Animal Health External Anthelmintic for Dogs Product Portfolio
- 8.7.5 Merck Animal Health Recent Developments
- 8.8 Elanco
- 8.8.1 Elanco Company Information
- 8.8.2 Elanco Business Overview
- 8.8.3 Elanco External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Elanco External Anthelmintic for Dogs Product Portfolio
- 8.8.5 Elanco Recent Developments
- 8.9 Boehringer Ingelheim
- 8.9.1 Boehringer Ingelheim Company Information
- 8.9.2 Boehringer Ingelheim Business Overview
- 8.9.3 Boehringer Ingelheim External Anthelmintic for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Boehringer Ingelheim External Anthelmintic for Dogs Product Portfolio
- 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 External Anthelmintic for Dogs Value Chain Analysis
- 9.1.1 External Anthelmintic for Dogs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 External Anthelmintic for Dogs Sales Mode & Process
- 9.2 External Anthelmintic for Dogs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 External Anthelmintic for Dogs Distributors
- 9.2.3 External Anthelmintic for Dogs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst